Susquehanna International Group
VRXA

Susquehanna International Group’s Veraxa Biotech AG VRXA Stock Holding History

Susquehanna International Group’s Portfolio VRXA Stock Details VRXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4K Buy
+10,833
New +$86.6K ﹤0.01% 13045

Other funds holding VRXA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Susquehanna International Group's VRXA Position: Q2 2026 in Review

Susquehanna International Group opened a new position in Veraxa Biotech AG (VRXA) in Q2 2026: 10,833 shares worth $20.4K. The stake represents ﹤0.01% of the portfolio and ranks #13045 among its holdings.

8 funds tracked by Wall St. Rank hold VRXA as of Q2 2026.

  • Susquehanna International Group held 10,833 shares of Veraxa Biotech AG worth $20.4K as of Q2 2026.
  • Veraxa Biotech AG was a new Susquehanna International Group position in Q2 2026.
  • Veraxa Biotech AG made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #13045 holding.
  • 8 funds tracked by Wall St. Rank held Veraxa Biotech AG as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.